Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.

Pharmaceutical

Siegfried Holding

Wolfgang Wienand

Peter Stierli

Henrik Krüpper

Irene Wosgien

Jürgen Roos

Reto Suter

Marianne Späne

Marcel Imwinkelried

Quality Assurance and Control

Analytical Development and Support

Leadership Team

Operations and Engineering

��

Teams at Siegfried Holding

Quality Assurance and Control

Analytical Development and Support

Leadership Team

Operations and Engineering

��������

Teams at Siegfried Holding

Quality Assurance and Control

Analytical Development and Support

Leadership Team

Operations and Engineering

��